Antibody Based Therapy in Coronary Artery Disease and Heart Failure
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 2
Abstract
The function of the immune system is to protect the host against disease. Antibodies are a key part of the adaptive response, recognising specific antigens and invading pathogens and marking them for destruction or blocking their activities. A mechanistic and molecular understanding of this process has allowed researchers to harness their natural function. They are now routinely used as a diagnostic tool in the clinic and in research to investigate pathological signalling. More recently, antibodies have been utilised for another application – therapy. Antibody based therapy is one of the newest and fastest growing with nearly 70 approved drugs to date and over 1000 in clinical trials. Investment from the pharmaceutical sector shows no signs of abating and this technology is now widely accepted for treating cancer, autoimmune and infectious diseases. In the context of the cardiovascular system however, antibody therapies are relatively limited. This review summarises the monoclonal antibodies approved for clinical use or currently in clinical trials for treating cardiovascular disorders. Presently, coronary artery disease, heart failure and transplant are the main indications, and monoclonal antibody therapies are discussed in the context of their specific applications.
Authors and Affiliations
Lorna R. Fiedler
Keywords
Related Articles
- EP ID EP558218
- DOI 10.17140/HROJ-4-140
- Views 150
- Downloads 0
Nicorandil: What is Beyond the Anti-Anginal Action?
Incidence of Contrast Induced Nephropathy (CIN) among ischemic heart disease patients subjected to coronary catheterization is highly dependent on the kidney function before contrast media administration and relevant ris...
Saroglitazar: A New Drug to Treat Diabetic Hypertriglyceridemia
Dyslipidemia alone has been considered as one of the major modifiable risk factor for cardiovascular diseases (CVD) accounting for 50% of the 1st myocardial infarction (MI) cases worldwide.1 A recent epidemiological sur...
Autonomic Dysfunction, Sympathetic Hyperactivity and the Development of End-Organ Damage in Hypertension: Multiple Benefits of Exercise Training
Autonomic dysfunction is closely related to the development of hypertension, which is characterized by increased sympathetic activity, decreased vagal tonus and baroreflex dysfunction. The hypertension-induced maladaptiv...
The PLATFORM Trial: An Insight into the Improved Value of Using FFRCT for Reduction of Invasive Angiographic Procedures
Coronary CT Angiography (CCTA) has been widely used as a reliable non-invasive modality for the diagnosis of Coronary Artery Disease (CAD) due to its improved spatial and temporal resolution.1-5For patients with low to i...
Inhibiting the Inhibitors, PTP1B as a Therapeutic Target in Myocardial Infarction
Biological systems self-regulate through cycles of activation and inactivation, the balance of which is critical in permitting or suppressing signaling cascades and their downstream consequences. Kinase signaling pathway...